Fat accumulation and HIV-1 protease inhibitors (multiple letters) [11]

Lancet

Volumn 352, Issue 9137, 1998, Pages 1392-

  Stricker, R B ^a   Goldberg, B ^a   Martinez, E ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CATHEPSIN; CELL ENZYME; INSULIN; PROTEINASE INHIBITOR;

HUMAN; LETTER; LIPID STORAGE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0032564198     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60792-1     Document Type: Letter

References (5)

1. E Martinez J Gatell Metabolic abnormalities and use of HIV-1 protease inhibitors Lancet 352 1998 821 822
2. B Goldberg RB Stricker HIV protease and the pathogenesis of AIDS Res Virol 147 1996 375 379
3. RB Stricker B Goldberg Weight gain associated with protease inhibitor therapy in HIV-infected patients Res Virol 149 1998 123 126
4. F Authier JS Mort AW Bell BI Posner JJ Bergeron Proteolysis of glucagon within hepatic endosomes by cathespins B and D J Biol Chem 270 1995 15798 15807
5. M Cclaussen B Kubler M Wendland Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathespin D Endocrinology 138 1997 3797 3803